ONT

Oxford Nanopore reports FY2025 revenue ahead of guidance

Oxford Nanopore Technologies expects to report full year 2025 revenue of approximately £223–£224 million, representing around 22% reported growth and 24% growth at constant currency, slightly ahead of guidance...

Oxford Nanopore Technologies to participate in January investor conferences

Oxford Nanopore Technologies will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco and the dbAccess UK & Ireland Conference in London during January...

Oxford Nanopore names Francis Van Parys as new CEO from March 2026

Oxford Nanopore Technologies has appointed Francis Van Parys as Chief Executive Officer, effective 2 March 2026...

Oxford Nanopore CEO Gordon Sanghera to step down

Oxford Nanopore has announced that CEO and co-founder Gordon Sanghera will step down by the end of 2026 after more than 20 years leading the company. The Board has begun a formal search for his successor as part of its succession planning, aiming to guide the business through its next phase of growth and commercialisation...

Oxford Nanopore delivers 25% revenue growth in H1 2025

Revenue rose to £105 million, up 28% constant currency, driven by PromethION growth of 59% and strong gains in Applied markets. Adjusted EBITDA loss narrowed, cash stood at £337 million and full‑year guidance remains on track...

Oxford Nanopore unveils tech and pipeline updates at London Calling 2025

Oxford Nanopore Technologies recently unveiled innovative updates at its London Calling conference, showcasing advancements in nanopore sequencing technology and its applications...
Search

Funds

UK Broker Ratings

Oxford Nanopore reports FY2025 revenue ahead of guidance

Oxford Nanopore Technologies expects to report full year 2025 revenue of approximately £223–£224 million, representing around 22% reported growth and 24% growth at constant currency, slightly ahead of guidance...

Oxford Nanopore Technologies to participate in January investor conferences

Oxford Nanopore Technologies will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco and the dbAccess UK & Ireland Conference in London during January...

Oxford Nanopore names Francis Van Parys as new CEO from March 2026

Oxford Nanopore Technologies has appointed Francis Van Parys as Chief Executive Officer, effective 2 March 2026...

Oxford Nanopore CEO Gordon Sanghera to step down

Oxford Nanopore has announced that CEO and co-founder Gordon Sanghera will step down by the end of 2026 after more than 20 years leading the company. The Board has begun a formal search for his successor as part of its succession planning, aiming to guide the business through its next phase of growth and commercialisation...

Oxford Nanopore delivers 25% revenue growth in H1 2025

Revenue rose to £105 million, up 28% constant currency, driven by PromethION growth of 59% and strong gains in Applied markets. Adjusted EBITDA loss narrowed, cash stood at £337 million and full‑year guidance remains on track...

Oxford Nanopore unveils tech and pipeline updates at London Calling 2025

Oxford Nanopore Technologies recently unveiled innovative updates at its London Calling conference, showcasing advancements in nanopore sequencing technology and its applications...
Search

Funds

ONT

FTSE 100

Funds